ID
42533
Beskrivning
Study ID: 105874 Clinical Study ID: 105874 Study Title: Bridging Safety & Immunogenicity Study of GSK Biologicals' Candidate Malaria Vaccine RTS,S/AS01E (0.5 mL Dose) to RTS,S/AS02D (0.5 mL Dose) Administered IM According to a 0, 1, 2-Month Schedule in Gabonese Children Aged 18 Months to 4 Years Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00307021 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049 Trade Name: N/A Study Indication: Malaria ODM derived from https://clinicaltrials.gov/ct2/show/NCT00307021. A Phase II randomized, double-blind bridging study of the safety and immunogenicity of GlaxoSmithKline Plasmodium falciparum malaria vaccine RTS,S/AS01E (0.5 mL dose) to RTS,S/AS02D (0.5 mL dose) administered IM according to a 0, 1, 2- month vaccination schedule in children aged 18 months to 4 years living in Gabon. Clinical Visits: This study has a total of 7 visits. Visit 1 = Screening, Visits 2-6 are during the double-blind phase (Month 0-3) and Visit 7 is during the single-blind phase (Month 4-14). Vaccine administration takes place during visits 2, 4, and 5 (Visit 2 = Dose 1; Visit 4 = Dose 2; Visit 5 = Dose 3). Field-worker Visits: During the double-blind phase, clinical visits are accompanied by daily field-worker visits subsequent to each vaccine administration visit. Additional field-worker visits also take place during months 4 to 13 of the single-blind phase. Randomisation / Treatment Allocation takes place at visit 2 prior to the first vaccination. The subsequent record treatment number should documented at visit 2. Information on the subject's demographics, body weight, and HBV immunization status (incl. vaccination dates) should also be recorded at clinical visit 2. Please note that informed consent has to be obtained prior to any study procedure.
Länk
https://clinicaltrials.gov/ct2/show/NCT00307021
Nyckelord
Versioner (1)
- 2021-08-24 2021-08-24 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
24 augusti 2021
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Safety & Immunogenicity of two GSK Biologicals' Candidate Malaria Vaccines in young children, NCT00307021
Demographics, Randomisation, Weight, and HBV Immunization Status
- StudyEvent: ODM
Beskrivning
Demographics
Alias
- UMLS CUI-1
- C0011298
Beskrivning
Randomisation / Treatment allocation
Alias
- UMLS CUI-1
- C0034656
- UMLS CUI-2
- C1522541
Beskrivning
Body weight
Alias
- UMLS CUI-1
- C0005910
Beskrivning
HBV immunization status
Alias
- UMLS CUI-1
- C0552506
- UMLS CUI-2
- C0019163
Beskrivning
If Yes, please provide the dates of the first, second, and third vaccination in the items below.
Datatyp
boolean
Alias
- UMLS CUI [1,1]
- C2240392
- UMLS CUI [1,2]
- C2368628
Beskrivning
Date in time hepatitis B vaccine administration (1st)
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C2240392
- UMLS CUI [1,3]
- C2368628
- UMLS CUI [1,4]
- C0205435
Beskrivning
Date in time hepatitis B vaccine administration (2nd)
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C2240392
- UMLS CUI [1,3]
- C2368628
- UMLS CUI [1,4]
- C0205436
Beskrivning
Date in time hepatitis B vaccine administration (3rd)
Datatyp
date
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C2240392
- UMLS CUI [1,3]
- C2368628
- UMLS CUI [1,4]
- C0205437
Similar models
Demographics, Randomisation, Weight, and HBV Immunization Status
- StudyEvent: ODM
C1522541 (UMLS CUI-2)
C0600091 (UMLS CUI [1,2])
C0019163 (UMLS CUI-2)
C2368628 (UMLS CUI [1,2])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205435 (UMLS CUI [1,4])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205436 (UMLS CUI [1,4])
C2240392 (UMLS CUI [1,2])
C2368628 (UMLS CUI [1,3])
C0205437 (UMLS CUI [1,4])